Amarin Finds New Target in Skinny Label Patent Cases: Insurers

Amarin Pharma Inc. is testing a novel legal argument in a patent lawsuit over its heart medicine Vascepa that, if successful, could expose health insurance companies to new infringement claims in generic drug disputes.

Amarin has accused Health Net LLC of inducing pharmacies to dispense, and patients to use, Hikma Pharmaceuticals Plc’s copycat medicine in a way that infringes Amarin patents. Amarin’s allegation is part of its attempt to fight off generic competition for Vascepa.

Magistrate Judge Jennifer Hall recently recommended Amarin be allowed to proceed with its argument, while noting the novelty of trying to hold a health ...